Biphasic insulin aspart compared to biphasic human insulin reduces postprandial hyperlipidemia in patients with Type 2 diabetes

Experimental and Clinical Endocrinology and Diabetes

Volumn 113, Issue 3, 2005, Pages 176-181

  Schmoelzer, I ^a   De Campo, A ^a   Pressl, H ^a   Stelzl, H ^a   Dittrich, P ^a   Oettl, K ^a   Wascher, Thomas C ^a,b  

^a UNIVERSITY OF GRAZ   (Austria)

^b NONE   (Austria)

Author keywords

Insulin aspart; Postprandial hyperlipidemia; Type 2 diabetes

Indexed keywords

BHI 30; BIASP 30; BIPHASIC INSULIN; C PEPTIDE; CHYLOMICRON; GLUCOSE; HEMOGLOBIN A1C; HUMAN INSULIN; INSULIN; INSULIN ASPART; RETINOL PALMITATE; TRIACYLGLYCEROL;

ADULT; AREA UNDER THE CURVE; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DISEASE DURATION; DRUG EFFECT; DRUG FORMULATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIPID METABOLISM; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TEST MEAL; TREATMENT OUTCOME; TRIACYLGLYCEROL BLOOD LEVEL;

CHYLOMICRON REMNANTS; CHYLOMICRONS; CROSS-OVER STUDIES; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; HYPERLIPIDEMIAS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; POSTPRANDIAL PERIOD; TIME FACTORS; VITAMIN A;

EID: 17144406856     PISSN: 09477349     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2005-837521     Document Type: Article

References (33)

1. Cavallero E, Dachte C, Neuflor D, Wirquin E, Mathe D, Jacotot B. Post-prandial amplification of lipoprotein abnormalities in controlled type II diabetic subjects: relationship to postprandial lipemia and C-peptide/glucagon levels. Metabolism 1994; 43: 270-278
2. Ceriello A. The post-prandial state and cardiovascular disease: relevance to diabetes mellitus. Diabetes Metab Res Rev 2000; 16: 125-132
3. Charbonell B, Balarac N, Cazeneuve B, Augendre-Ferran F, Drouin P. Which are the insulin treatment regimens used in the "Schema Survey". Diabetes Metab 2001; 27: 591-597
4. Chen YD, Swami S, Skrowronski R, Coulston AM, Reaven GM. Differences in postprandial lipemia between patients with normal glucose tolerance and noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1993; 76: 172-177
5. Cortner JA, Coates PM, Le NA et al. Kinetics of chylomicron remnant clearance in normal and in hyperlipoproteinemic subjects. J Lipid Res 1987; 28: 195-206
6. De Man FHA, Cabezas MC, Van Barlingen HHJJ, Erkelens DW, De Bruin TWA. Triglyceride-rich lipoproteins in NIDDM, postprandial metabolism and relation to premature atherosclerosis. Eur J Clin Invest 1996; 26: 89-108
7. Eckel RH. Lipoprotein lipase. A multifactorial enzyme relevant to common metabolic disease. N Engl J Med 1989; 320: 106-68
8. Fontbonne A, Eschwege E, Cambien F et al. Hypertriglyceridaemia as a risk factor of coronary artery disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the Paris Prospective Study. Diabetologia 1989; 32: 300-304
9. Geltner CH, Lechleitner M, Föger B, Ritsch A, Drexel H, Patsch JR. Insulin improves fasting and postprandial lipemia in type II diabetes. EJIM 2002; 13: 256-263
10. Gibbons GF, Brown AM, Wiggins D, Rease R. The roles of insulin and fatty acids in the regulation of hepatic very-low-density lipoprotein assembly. J R Soc Med 2002; 95 (Suppl 42): 23-32
11. Ginsberg HN, Illingworth DR. Postprandial dyslipidemia: an atherogenic disorder common in patients with diabetes mellitus. Am J Cardiol 2001; 88: 9 H-15 H
12. Ginsberg HN. Lipoprotein physiology in nondiabetic and diabetic states. Diabetes Care 1991; 14: 839-855
13. Hermansen K, Colombo M, Storgaard H, Ostergaard A, Kolendorf K, Madsbad S. Improved postprandial glycemic control with biphasic insulin aspart relative to biphasic insulin lispro and biphasic human insulin in patients with type II diabetes. Diabetes Care 2002 a; 25: 883-888
14. Hermansen K, Vaaler S, Madsbad S, Dalgaard M, Zander M, Begtru K, Soendetgaard K. Postprandial glycemic control with biphasic insulin aspart in patients with type I diabetics. Metabolism 2002 b; 51: 896-900
15. Home PD, Lindholm A, Hylleberg B, Round P. Improved glycemic control with insulin aspart. Diabetes Care 1998; 21: 1904-1909
16. Katsilambros N. Postprandial hypertriglyceridaemia. Diabet Med 1995; 12: 451-452
17. Krasínski SD, Cohn JS, Russel RM, Schaefer EJ. Postprandial plasma vitamin A metabolism in humans: a reassessment of the use of plasma retinyl esters as markers for intestinally derived chylomicrons and their remnants. Metabolism 1990; 39: 357-365
18. Lewis GF, Uffelman KD, Szeto LW, Steiner G. Effects of acute hyperinsulinemia on VLDL triglyceride and VLDL apoB production in normal weight and obese individuals. Diabetes 1993; 42: 833-842
19. Lindholm A, McEwen J, Riis AP. Improved postprandial glycemic control with insulin aspart: a randomized double-blind cross-over trial in type 1 diabetes. Diabetes Care 1999; 22: 801-805
20. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment. Insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419
21. McNamara JR, Paulesh KS, Nakajima K, Cupples LA, Wilson PWF, Ordovas JM, Schaefer EJ. Remnant-like particle (RLP) cholesterol is an independent cardiovascular disease risk factor in women: results from the Framingham Heart sStudy. Atherosclerosis 2001; 154: 229-236
22. Patsch JR, Miesenböck G, Hopferwieser T et al. The relationship of triglyceride metabolism and coronary heart disease: studies in the post-prandial state. Arterioscler Thromb Vasc Biol 1992; 12: 1336-1345
23. Patsch W, Franz S, Schonfeld G. Role of insulin on lipoprotein secretion by cultured rat hepatocytes. J Clin Invest 1983; 71: 1161-1174
24. Patsch W, Gotto AM, Patsch JR. Effects of insulin on lipoprotein secretion in rat hepatocyte cultures. J Biol Chem 1986; 21: 9603-9606
25. Potts JL, Fisher RM, Humphreys SM, Gibbson GF, Fray KN. Separation of lipoprotein fractions by ultracentrifugation: investigation of analytic recovery with sequential flotation and density gradient procedures. Clinica Chimica Acta 1994; 230: 215-220
26. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Res Rev 1987; 3: 463-524
27. Roach P, Yue L, Arora V. Improved postprandial glycemic control during treatment with Humalog Mix25, a novel protamine-based insulin lispro formulation: Humalog Mix25 Study Group. Diabetes Care 1999; 22: 1258-1261
28. Schaefer EJ, Mc Namara JR, Shah PK, Nakajima K, Cupples LA, Ordovas JM, Wilson PW. Elevated remnant-like particle cholesterol and triglyceride levels in diabetic men and women in the Framingham Offspring Study. Diabetes Care 2002; 25: 989-994
29. Skrapari I, Perrea D, Ionnidis I, Karabina SAP, Elisaf M, Tselepis AD, Karagiannacos P, Katsilambros N. Glibenclamide improves postprandial hypertriglyceridaemia in type II diabetic patients by reducing chylomicrons but not the very low-density lipoprotein subfraction levels. Diabet Med 2001; 18: 781-785
30. Sowell AL, Huff DL, Yeager PR, Caudill SP, Gunter EW. Retinol, alpha-tocopherol, lutein/zeaxantin, beta-cryptoxanthin, lycobene, alpha-carotene, trans-beta-carotene and four retinylesters in serum determined simultaneously by reversed-phase HPLC with multiwavelengh detection. Clin Chem 1994; 40: 411-416
31. Sprecher DL, Knauer SL, Black DM. Chylomicron-retinyl palmitate clearance in type I hyperlipidemic families. J Clin Invest 1991; 88: 985-994
32. Syvänne M, Hilden H, Taskinen MR. Abnormal metabolism of postprandial lipoproteins in patients with non-insulin dependent diabetes mellitus is not related to coronary artery disease. J Lipid Res 1994; 35: 15-26
33. Zilversmit DB. Atherogenesis: a postprandial phenomenon. Circulation 1979; 60: 473-485